PROPHARMA GROUP UK LTD

04311940
Active Richmond

Other business support service activities n.e.c.

0 employees website.com
Other business support service activities n.e.c.
P

PROPHARMA GROUP UK LTD

04311940

Other business support service activities n.e.c.

Founded 26 Oct 2001 Active Richmond, United Kingdom 0 employees website.com
Other business support service activities n.e.c.

Previous Company Names

XENDO UK LTD 5 Jan 2016 — 31 Jan 2019
VIGILEX LTD. 26 Oct 2001 — 5 Jan 2016
Accounts Submitted 22 Mar 2026 Next due 19 Mar 2026 4 months overdue
Confirmation
Net assets £78K £166 2024 year on year
Total assets £84K £179 2024 year on year
Total Liabilities £6K £13 2024 year on year
Charges 7
4 outstanding 3 satisfied

Contact & Details

Contact

Registered Address

Olliver Aske Richmond North Yorkshire DL10 5HX United Kingdom

Telephone

0800 000 0000

Email

info@example.com

Website

www.example.com

Full company profile for PROPHARMA GROUP UK LTD (04311940), an active company based in Richmond, United Kingdom. Incorporated 26 Oct 2001. Other business support service activities n.e.c.. View financials, directors, shareholders, and filings.

Business Summary

This company specializes in providing innovative solutions and services across multiple sectors.

Products & Services

consulting software analytics integration

Reports

Credit Report

In-depth credit score, financial analysis, risk assessment and company intelligence.

Financials

Financials

Period 1 Jan → 31 Dec 2024
Type audit-exemption-subsidiary
Next accounts 28 Dec 2024
Due by 19 Mar 2026 4 months overdue

Balance Sheet & P&L (2013–2024)

Cash in Bank

N/A

Net Assets

£77.98k

Decreased by £166.00 (-0%)

Total Liabilities

£6.40k

Decreased by £13.00 (-0%)

Turnover

N/A

Employees

N/A

Debt Ratio

8%

Financial History

Revenue, profit, EBITDA and key financial figures

2024
31 Dec Year End
2023
31 Dec Year End
P&L
Revenue
£142.3M
£128.7M
Gross Profit
£48.2M
£43.1M
Operating Profit
£22.4M
£19.8M
Net Profit
£18.1M
£15.9M
EBITDA
£31.5M
£28.2M
Assets
Cash
£24.7M
£21.3M
Total Assets
£89.4M
£82.1M
Liabilities
Total Liabilities
£45.2M
£41.8M
Key Metrics
Employees
1,247
1,156
Latest Revenue
£142.3M
Latest EBITDA
£31.5M
Cash Position
£24.7M

Funding

Fundraising & Grants

No fundraising or grants recorded

Investors (0)

No investor information available

Officers

Officers

0 active 3 resigned
Status

No officers found

No officers found

Shareholders

Shareholders (1)

Xendo Holding Bv
100.0%
1

Persons with Significant Control

Persons with Significant Control (1)

1 Active 1 Ceased
Active
Notified 13 Jul 2018
Nature of Control
  • Ownership Of Shares 75 To 100 Percent

Xendo Holding Bv

Ceased 13 Jul 2018

Ceased

Group Structure

Group Structure

PROPHARMA GROUP UK LTD Current Company

Charges

Charges

4 outstanding 3 satisfied

Properties

Properties

0 total

No related properties

Documents

Company Filings

DateCategoryDescriptionDocument
22 Mar 2026AccountsAnnual accounts made up to 31 Dec 2024
22 Mar 2026OtherAudit exemption statement of guarantee by parent company for period ending 31/12/24
22 Mar 2026AccountsAnnual accounts filed
22 Mar 2026OtherNotice of agreement to exemption from audit of accounts for period ending 31/12/24
22 Mar 2026AccountsAnnual accounts filed
22 Mar 2026 Accounts

Annual accounts made up to 31 Dec 2024

22 Mar 2026 Other

Audit exemption statement of guarantee by parent company for period ending 31/12/24

22 Mar 2026 Accounts

Annual accounts filed

22 Mar 2026 Other

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

22 Mar 2026 Accounts

Annual accounts filed

Recent Activity

Latest Activity

Annual accounts made up to 31 Dec 2024

3 months ago on 22 Mar 2026

Audit exemption statement of guarantee by parent company for period ending 31/12/24

3 months ago on 22 Mar 2026

Annual accounts filed

3 months ago on 22 Mar 2026

Notice of agreement to exemption from audit of accounts for period ending 31/12/24

3 months ago on 22 Mar 2026

Annual accounts filed

3 months ago on 22 Mar 2026